SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-15-001383
Filing Date
2015-02-17
Accepted
2015-02-17 11:58:51
Documents
1
Group Members
VIVO VENTURES FUND VI L.P.VIVO VENTURES FUND VII L.P.VIVO VENTURES VI AFFILIATES FUND L.P.VIVO VENTURES VII AFFILIATES FUND L.P.VIVO VENTURES VII LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 a213154sc13ga1.htm SC 13G/A 199858
  Complete submission text file 0001214659-15-001383.txt   201674
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86177 | Film No.: 15619695
SIC: 2834 Pharmaceutical Preparations

Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VI, LLC (Filed by) CIK: 0001469547 (see all company filings)

IRS No.: 208829402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A